Navigation Links
Sinexus Welcomes New CEO and Completes Series B
Date:6/5/2008

n providing improved treatment for their patients. Sinexus' initial focus is treating patients with Chronic Rhinosinusitis, a debilitating chronic condition that affects one out of seven adults in the United States.

About PTV Sciences

PTV Sciences (http://www.ptvsciences.com), founded in 2003, is a leading life science venture capital firm focused on building industry leading companies and investing in extraordinary people. PTV Sciences has a team of investment professionals and 13 venture partners representing the leading clinicians, scientists, academic institutions, and entrepreneurs. PTV Sciences has offices in Austin and Houston, Texas.

About Kleiner Perkins Caufield & Byers

Since its founding in 1972, Kleiner Perkins Caufield & Byers (KPCB, http://www.kpcb.com) has backed entrepreneurs in over 500 ventures, including AOL, Amazon.com, Citrix, Compaq Computer, Electronic Arts, Genentech, Genomic Health, Google, Intuit, Juniper Networks, Netscape, Lotus, Sun Microsystems, Symantec, VeriSign and Xilinx. In February 2008, KPCB announced its $100 million iFund initiative targeted at innovation in the Apple iPhone and iTouch platform. KPCB portfolio companies employ more than 250,000 people. More than 150 of the firm's portfolio companies have gone public. Many other ventures have achieved success through mergers and acquisitions.

About U.S. Venture Partners

U.S. Venture Partners (USVP, http://www.usvp.com) is a leading Silicon Valley-based venture capital firm, dedicated to helping entrepreneurs build world-class companies that are leaders in their industry. Since 1981, when it was founded, USVP has raised a total of more than $2.9 billion in nine venture capital funds and invested in more than 390 early stage companies, 74 of which to date have become public companies by IPO
'/>"/>

SOURCE Sinexus, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Womens World Banking Welcomes New Network Member From Tunisia
2. MJGC Welcomes New Administrator-in-Training Shlomo Katz
3. MJGC Welcomes New Director of Social Work Alla Lerner
4. Patient Advocate Foundation Welcomes Leading Health Care Experts to Executive Board of Directors
5. Friends of WFP Welcomes World Hunger Relief Week
6. New York City Aesthetic Plastic Surgeon Welcomes top Skin Care Line into his Office
7. St. Pauls Senior Homes & Services Welcomes Some of San Diegos Neediest Displaced Seniors
8. HealthCoach Welcomes James Herrera as Vice President of Consulting
9. Delmarva Foundation Welcomes New Chief Operating Officer
10. Boston Scientific Welcomes FDA Panel Recommendation to Approve PROMUS(TM) / XIENCE(TM) V Everolimus-eluting Coronary Stent System
11. Truthful Labeling Coalition Welcomes Perdue Farms
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Allegheny Medical Achieves Remarkable Success with Their Fibromyalgia Flow Care Plan 2Health News:Allegheny Medical Achieves Remarkable Success with Their Fibromyalgia Flow Care Plan 3Health News:Study highlights implications of influenza pandemics on blood supplies 2Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 2Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 3Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 4Health News:Ronald McDonald Care Mobile(R) Brings Dental Care to Area Schools 2Health News:Ronald McDonald Care Mobile(R) Brings Dental Care to Area Schools 3Health News:Ronald McDonald Care Mobile(R) Brings Dental Care to Area Schools 4Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 4
Breaking Medicine Technology:Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 3Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 4Elsevier Selects BrainTrack Directory as Supplier of College Data 2Elsevier Selects BrainTrack Directory as Supplier of College Data 3Elsevier Selects BrainTrack Directory as Supplier of College Data 4ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer 2Hoya Announces First Quarter Financial Results for FY2010 13321 1Hoya Announces First Quarter Financial Results for FY2010 13321 2Sports Icons Troy Aikman Clyde Drexler Mike Piazza Ivan Lendl and Dara Torres are Among the Elite Named 2009 Great Sports Legends 53448 1Sports Icons Troy Aikman Clyde Drexler Mike Piazza Ivan Lendl and Dara Torres are Among the Elite Named 2009 Great Sports Legends 53448 2Sports Icons Troy Aikman Clyde Drexler Mike Piazza Ivan Lendl and Dara Torres are Among the Elite Named 2009 Great Sports Legends 53448 3Sports Icons Troy Aikman Clyde Drexler Mike Piazza Ivan Lendl and Dara Torres are Among the Elite Named 2009 Great Sports Legends 53448 4Madzone Marketing LLC Taps TransMedia Group to Provide Publicity Lift to Knife and Forklift 28TM 29 53445 1Madzone Marketing LLC Taps TransMedia Group to Provide Publicity Lift to Knife and Forklift 28TM 29 53445 2
Other Medicine Technology:BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine 2Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 2Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 3Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 4Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 5Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 6